WallStreetZenWallStreetZen

NASDAQ: GH
Guardant Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for GH

Based on 12 analysts offering 12 month price targets for Guardant Health Inc.
Min Forecast
$35.00+7.13%
Avg Forecast
$52.92+61.97%
Max Forecast
$73.00+123.45%

Should I buy or sell GH stock?

Based on 12 analysts offering ratings for Guardant Health Inc.
Strong Buy
Strong Buy
8 analysts 66.67%
Buy
3 analysts 25%
Hold
1 analysts 8.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GH stock forecasts and price targets.

GH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Citigroup
Top 7%
94
Strong BuyUpgrades$40.00+22.44%2023-05-26
Morgan Stanley
Top 29%
72
Strong BuyMaintains$60.00+83.65%2023-05-11
Credit Suisse
Top 7%
94
BuyMaintains$55.00+68.35%2023-05-10
Piper Sandler
Top 17%
84
HoldMaintains$35.00+7.13%2023-03-03
BTIG
Top 34%
67
Strong BuyMaintains$50.00+53.05%2023-02-24
Canaccord Genuity
Bottom 4%
4
Strong BuyMaintains$60.00+83.65%2023-02-24
Cowen & Co.
Bottom 5%
5
BuyMaintains$53.00+62.23%2023-02-24
JP Morgan
Top 31%
70
Strong BuyMaintains$65.00+98.96%2023-02-24
Morgan Stanley
Bottom 7%
7
Strong BuyMaintains$73.00+123.45%2023-02-21
Stephens & Co.
Bottom 2%
2
Strong BuyReiterates$63.00+92.84%2023-02-16

1 of 2

Forecast return on equity

Is GH forecast to generate an efficient return?

Forecast return on assets

Is GH forecast to generate an efficient return on assets?
Company
-34.33%
Industry
11.03%
GH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GH revenue growth forecast

How is GH forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
28.32%
Industry
5.97%
Market
16.46%
GH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
GH$32.67$52.92+61.97%Strong Buy
PACB$13.62$14.17+4.02%Buy
NEOG$19.14$17.00-11.18%Hold
SHC$14.97$20.25+35.27%Buy
OLK$20.52$23.00+12.09%Buy

Guardant Health Stock Forecast FAQ

Is Guardant Health Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: GH) stock is to Strong Buy GH stock.

Out of 12 analysts, 8 (66.67%) are recommending GH as a Strong Buy, 3 (25%) are recommending GH as a Buy, 1 (8.33%) are recommending GH as a Hold, 0 (0%) are recommending GH as a Sell, and 0 (0%) are recommending GH as a Strong Sell.

If you're new to stock investing, here's how to buy Guardant Health stock.

What is GH's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: GH) forecast ROE is N/A, which is considered weak.

What is GH's Price Target?

According to 12 Wall Street analysts that have issued a 1 year GH price target, the average GH price target is $52.92, with the highest GH stock price forecast at $73.00 and the lowest GH stock price forecast at $35.00.

On average, Wall Street analysts predict that Guardant Health's share price could reach $52.92 by May 26, 2024. The average Guardant Health stock price prediction forecasts a potential upside of 61.97% from the current GH share price of $32.67.

What is GH's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: GH) forecast ROA is -34.33%, which is lower than the forecast US Diagnostics & Research industry average of 11.03%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.